Atlas Trials

Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer

Clinical trial NCT04869371 · UNKNOWN

Trial details

NCT number
NCT04869371
Sponsor
Hongqian Guo
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel
Start date
2018-12-12
Primary completion
2020-12-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.